JP2011515672A - 腎尿細管の損傷および疾患の診断のための方法およびマーカー - Google Patents
腎尿細管の損傷および疾患の診断のための方法およびマーカー Download PDFInfo
- Publication number
- JP2011515672A JP2011515672A JP2011500224A JP2011500224A JP2011515672A JP 2011515672 A JP2011515672 A JP 2011515672A JP 2011500224 A JP2011500224 A JP 2011500224A JP 2011500224 A JP2011500224 A JP 2011500224A JP 2011515672 A JP2011515672 A JP 2011515672A
- Authority
- JP
- Japan
- Prior art keywords
- markers
- sample
- marker
- polypeptide
- renal tubular
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/34—Genitourinary disorders
- G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Biophysics (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
診断のためのポリペプチドマーカーの検出に、尿を用いた。尿は健常ドナー(対照群)から、および腎疾患を罹患する患者から採取した。
Beckman Coulterキャピラリー電気泳動システム(P/ACE MDQシステム;Beckman Coulter社、Fullerton、CA、米国)およびBruker ESI−TOF質量分析計(micro−TOF MS、Bruker Daltonik、Bremen、ドイツ)を用いてCE−MS測定を行った。
CE測定をチェックおよび標準化するため、記述されている選択された条件下でのCE移動時間で特徴付けられる次のタンパク質またはポリペプチドを用いた。
Claims (14)
- 尿試料中の少なくとも1種のポリペプチドマーカーの有無または強度を測定する工程を含む腎尿細管疾患の診断のための方法であって、
前記ポリペプチドマーカーが表1の分子量および移動時間の値によって特徴付けられるマーカーから選択される、腎尿細管疾患の診断のための方法。 - 測定された前記マーカーの有無または強度の評価が、以下の表2に記載される基準値によって行われることを特徴とする、請求項1記載の方法。
- 請求項1で定義される少なくとも3種、少なくとも5種、少なくとも6種、少なくとも8種、少なくとも10種、少なくとも20種または少なくとも50種のポリペプチドマーカーが使用される、請求項1〜2の少なくとも1項に記載の方法。
- 患者からの前記試料が中間尿試料である、請求項1〜3のいずれかに記載の方法。
- キャピラリー電気泳動、HPLC、気相イオンスペクトロメトリーおよび/または質量分析を使用して前記ポリペプチドマーカーの有無または強度を検出する、請求項1〜4のいずれかに記載の方法。
- 前記ポリペプチドマーカーの分子量が測定されるよりも前にキャピラリー電気泳動が行われる、請求項1〜5のいずれかに記載の方法。
- 質量分析を用いて1種または複数種の前記ポリペプチドマーカーの有無が検出される、請求項1〜6のうちいずれかに記載の方法。
- 分子量および移動時間の値によって特徴付けられる表1のマーカーから選択される少なくとも3種のペプチドマーカーの、腎尿細管疾患の診断のための使用。
- a)試料を少なくとも3個の、好ましくは10個のサブサンプルに分ける工程;および
b)少なくとも5個のサブサンプルを分析して前記試料中の少なくとも1種のポリペプチドマーカーの有無または強度を測定し、ここで前記ポリペプチドマーカーは分子量および移動時間(CE時間)によって特徴付けられる表1のマーカーから選択される工程;
を含む、腎尿細管疾患の診断のための方法。 - 少なくとも10個のサブサンプルを測定する、請求項9記載の方法。
- 前記CE時間時間が、長さ90cm、内径(ID)50μmのガラスキャピラリーに25kVの電圧を印加することに基づくものであって、ここで20%アセトニトリル、0.25%ギ酸の水溶液が移動相として用いられることを特徴とする、請求項1〜10の少なくとも1項に記載の方法。
- 分子量および移動時間(CE時間)によって特徴付けられる表1のマーカーから選択される少なくとも10種のマーカーを含む、マーカーの組み合わせ。
- 感度が少なくとも60%であり、特異性が少なくとも40%である、請求項1〜7または9〜11の少なくとも1項に記載される方法。
- 前記マーカーの質量が≦5kDaであることを特徴とする、請求項1〜7または9〜11または13の少なくとも1項に記載の方法。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08153007 | 2008-03-19 | ||
EP08153007.3 | 2008-03-19 | ||
EP08167429 | 2008-10-23 | ||
EP08167429.3 | 2008-10-23 | ||
PCT/EP2009/053242 WO2009115570A2 (de) | 2008-03-19 | 2009-03-19 | Verfahren und marker zur diagnose von tubulären nierenschäden und -erkrankungen |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2011515672A true JP2011515672A (ja) | 2011-05-19 |
JP2011515672A5 JP2011515672A5 (ja) | 2012-05-17 |
Family
ID=40671165
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2011500224A Pending JP2011515672A (ja) | 2008-03-19 | 2009-03-19 | 腎尿細管の損傷および疾患の診断のための方法およびマーカー |
Country Status (4)
Country | Link |
---|---|
US (1) | US20120037507A9 (ja) |
EP (1) | EP2255203A2 (ja) |
JP (1) | JP2011515672A (ja) |
WO (1) | WO2009115570A2 (ja) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060286602A1 (en) * | 2004-05-10 | 2006-12-21 | Harald Mischak | Method and markers for the diagnosis of renal diseases |
ATE519116T1 (de) * | 2007-03-07 | 2011-08-15 | Mosaiques Diagnostics & Therap | Verfahren zur normierung der konzentration von analyten in einer urinprobe |
EP1972940A1 (de) * | 2007-03-14 | 2008-09-24 | mosaiques diagnostics and therapeutics AG | Verfahren und Marker zur Diagnose von Nierenerkrankungen |
AU2008309605A1 (en) * | 2007-10-09 | 2009-04-16 | Mosaiques Diagnostics And Therapeutics Ag | Polypeptide marker for the diagnosis of prostate cancer |
EP2051078A1 (de) * | 2007-10-19 | 2009-04-22 | mosaiques diagnostics and therapeutics AG | Verfahren und Marker zur Diagnose von Diabetes Mellitus |
US20110214990A1 (en) * | 2008-09-17 | 2011-09-08 | Mosaiques Diagnostics And Therapeutics Ag | Kidney cell carcinoma |
CA2766228A1 (en) * | 2009-07-02 | 2011-01-06 | Mosaiques Diagnostics And Therapeutics Ag | Process and markers for the diagnosis of acute renal failure |
WO2011152339A1 (ja) * | 2010-05-31 | 2011-12-08 | Tanaka Noriaki | 慢性腎臓病の病期を判定する方法又は装置若しくはその作動方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007063090A1 (de) * | 2005-11-30 | 2007-06-07 | Mosaiques Diagnostics And Therapeutics Ag | Polypeptidmarker zur diagnostik und beurteilung der ureterabgangsstenose |
WO2007082586A1 (en) * | 2006-01-20 | 2007-07-26 | Mosaiques Diagnostics And Therapeutics Ag | Method and markers for the diagnosis of renal diseases |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5744101A (en) * | 1989-06-07 | 1998-04-28 | Affymax Technologies N.V. | Photolabile nucleoside protecting groups |
US6372249B1 (en) * | 1991-12-16 | 2002-04-16 | Baylor College Of Medicine | Senscent cell-derived inhibitors of DNA synthesis |
US6218122B1 (en) * | 1998-06-19 | 2001-04-17 | Rosetta Inpharmatics, Inc. | Methods of monitoring disease states and therapies using gene expression profiles |
EP1141728B1 (en) * | 1998-12-21 | 2007-10-17 | Monash University | Kidney disease detection and treatment |
US6677114B1 (en) * | 1999-04-20 | 2004-01-13 | Target Discovery, Inc. | Polypeptide fingerprinting methods and bioinformatics database system |
DE10021737C2 (de) * | 2000-05-04 | 2002-10-17 | Hermann Haller | Verfahren und Vorrichtung zur qualitativen und/oder quantitativen Bestimmung eines Protein- und/oder Peptidmusters einer Flüssigkeitsprobe, die dem menschlichen oder tierischen Körper entnommen wird |
WO2002004950A2 (en) * | 2000-07-12 | 2002-01-17 | Werner Naser | Direct assessment of analyte to reference molecule ratios |
US20030003588A1 (en) * | 2001-06-28 | 2003-01-02 | Comper Wayne D. | Method for kidney disease detection by protein profiling |
DE10304106A1 (de) * | 2003-01-31 | 2004-08-26 | Mosaiques Diagnostics And Therapeutics Ag | Verfahren und Vorrichtung zur qualitativen und/oder quantitativen Bestimmung eines Protein- und/oder Peptidmusters einer Flüssigkeitsprobe, die dem menschlichen oder tierischen Körper entnommen wird |
US7425700B2 (en) * | 2003-05-22 | 2008-09-16 | Stults John T | Systems and methods for discovery and analysis of markers |
DE10341193A1 (de) * | 2003-09-06 | 2005-03-31 | Mosaiques Diagnostics And Therapeutics Ag | Vorrichtung und Verfahren zur quantitativen Auswertung der in einer Körperflüssigkeitsprobe enthaltenden Polypeptide sowie Marker zur Erkennung von pathologischen Zuständen |
US20050244973A1 (en) * | 2004-04-29 | 2005-11-03 | Predicant Biosciences, Inc. | Biological patterns for diagnosis and treatment of cancer |
US20060286602A1 (en) * | 2004-05-10 | 2006-12-21 | Harald Mischak | Method and markers for the diagnosis of renal diseases |
DK2299275T3 (en) * | 2004-07-30 | 2018-05-07 | Adeza Biomedical Corp | Classification of oncofetal fetronectin level for pregnancy-related indications |
JP2008537112A (ja) * | 2005-04-07 | 2008-09-11 | モザイクヴェス ディアグノシュティクス アンド テラポイティクス アクチェン ゲゼルシャフト | 前立腺がんの診断のためのポリペプチドマーカー |
EP1757939A1 (de) * | 2005-08-26 | 2007-02-28 | mosaiques diagnostics and therapeutics AG | Polypeptidmarker zur Diagnose von Blasenkrebs |
ATE519116T1 (de) * | 2007-03-07 | 2011-08-15 | Mosaiques Diagnostics & Therap | Verfahren zur normierung der konzentration von analyten in einer urinprobe |
EP1972940A1 (de) * | 2007-03-14 | 2008-09-24 | mosaiques diagnostics and therapeutics AG | Verfahren und Marker zur Diagnose von Nierenerkrankungen |
AU2008309605A1 (en) * | 2007-10-09 | 2009-04-16 | Mosaiques Diagnostics And Therapeutics Ag | Polypeptide marker for the diagnosis of prostate cancer |
EP2051078A1 (de) * | 2007-10-19 | 2009-04-22 | mosaiques diagnostics and therapeutics AG | Verfahren und Marker zur Diagnose von Diabetes Mellitus |
US20110214990A1 (en) * | 2008-09-17 | 2011-09-08 | Mosaiques Diagnostics And Therapeutics Ag | Kidney cell carcinoma |
WO2010079076A2 (de) * | 2008-12-17 | 2010-07-15 | Mosaiques Diagnostics And Therapeutics Ag | Autosomal dominante polyzystische nierenerkrankung (adpkd) |
CA2766228A1 (en) * | 2009-07-02 | 2011-01-06 | Mosaiques Diagnostics And Therapeutics Ag | Process and markers for the diagnosis of acute renal failure |
WO2011029954A2 (de) * | 2009-09-14 | 2011-03-17 | Mosaiques Diagnostics And Therapeutics Ag | Polypeptidmarker zur diagnostik und beurteilung vaskulärer erkrankungen |
-
2009
- 2009-03-19 US US12/933,026 patent/US20120037507A9/en not_active Abandoned
- 2009-03-19 EP EP09722298A patent/EP2255203A2/de not_active Withdrawn
- 2009-03-19 JP JP2011500224A patent/JP2011515672A/ja active Pending
- 2009-03-19 WO PCT/EP2009/053242 patent/WO2009115570A2/de active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007063090A1 (de) * | 2005-11-30 | 2007-06-07 | Mosaiques Diagnostics And Therapeutics Ag | Polypeptidmarker zur diagnostik und beurteilung der ureterabgangsstenose |
WO2007082586A1 (en) * | 2006-01-20 | 2007-07-26 | Mosaiques Diagnostics And Therapeutics Ag | Method and markers for the diagnosis of renal diseases |
Also Published As
Publication number | Publication date |
---|---|
US20110036717A1 (en) | 2011-02-17 |
US20120037507A9 (en) | 2012-02-16 |
EP2255203A2 (de) | 2010-12-01 |
WO2009115570A2 (de) | 2009-09-24 |
WO2009115570A3 (de) | 2009-11-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20150024970A1 (en) | Kidney cell carcinoma | |
AU2006336091C1 (en) | Method and markers for the diagnosis of renal diseases | |
JP2011515672A (ja) | 腎尿細管の損傷および疾患の診断のための方法およびマーカー | |
US20140073057A1 (en) | Process and markers for the diagnosis of kidney diseases | |
AU2006283851B2 (en) | Polypeptide marker for the diagnosis of bladder cancer | |
US20150346150A1 (en) | Autosomal-dominant polycystic kidney disease (adpkd) | |
US20060286602A1 (en) | Method and markers for the diagnosis of renal diseases | |
US20100062537A1 (en) | Polypeptide Markers for the Diagnosis and Evaluation of Pelvi-Ureteric Junction Obstruction (PUJO) | |
US20150018246A1 (en) | Polypeptide marker for diagnosing and assessing vascular diseases | |
US20120118737A1 (en) | Method And Markers For Diagnosing Acute Renal Failure | |
JP2008537112A (ja) | 前立腺がんの診断のためのポリペプチドマーカー | |
US20100248378A1 (en) | Method and marker for diagnosing diabetes mellitus | |
JP2015507194A (ja) | 心不全の診断および評価のためのポリペプチドマーカー | |
CA2701571A1 (en) | Polypeptide markers for the diagnosis of prostate cancer | |
US20150126405A1 (en) | Polypeptide markers for the early recognition of the rejection of transplanted kidneys | |
JP5147684B2 (ja) | アルツハイマー病の診断のためのポリペプチドマーカー |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120319 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20120319 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20130227 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20131126 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20140220 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20140227 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20140819 |